Catalyst Wire Dossier Catalyst Wire Dossier

M0002

vasopressin V2 receptor antagonist · Movetis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M0002, covering 2010-08-11 to 2010-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia [Phase 2]

See pricing